Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

May 19, 2023

Study Completion Date

May 19, 2023

Conditions
Clinical TrialsImmunotherapy
Interventions
BEHAVIORAL

PINPOINT Digital Educational Tool

"The intervention prototype called the PINPOINT Digital Educational Tool will be comprised of four main sections that include information about: 1) precision oncology; 2) clinical trials; 3) Learn More screens; and 4) discussion points and questions for the treating clinician. The intervention prototype will also include a search function, short videos of patient testimonials, patient-provider interaction about immunotherapy and clinical trials, as well as a list of questions/concerns that the patient could print (or save electronically) and take with them to their provider visit. An optional chatbot will be available in the corner of the screen. Users can ask the chatbot questions about any of the material on the website or request additional information. The chatbot will also be able to help patients search for molecularly targeted and immunotherapy clinical trials and offer additional resources (such as websites and online support groups)."

Trial Locations (1)

08901

The Rutgers Cancer Institute, New Brunswick

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

collaborator

Pfizer

INDUSTRY

lead

Rutgers, The State University of New Jersey

OTHER